Nick talks to neuroscientist & psychologist, Dr. Chris Timmermann, ascientist at the Centre for Psychedelic Research at Imperial College London. Chris led the first neuroimaging studies on the effects of the potent tryptamine psychedelic DMT on the brain. They discussed DMT and related psychedelics, including how DMT is normally consumed in both recreational and laboratory contexts, how people describe its effects, how it compares to psychedelics like psilocybin and LSD, and whether it is an endogenous compound present in our own bodies. Chris also described his research on how DMT affects patterns of brain activity, and what he hopes to learn from ongoing research, which includes extending the duration of DMT experiences from a few minutes up to 30 minutes per session.
USEFUL LINKS:
Download the podcast & follow Nick at his website
[www.nickjikomes.com]
Support the show on Patreon & get early access to episodes
[https://www.patreon.com/nickjikomes]
Sign up for the weekly Mind & Matter newsletter
[http://eepurl.com/hFlc7H]
Try MUD/WTR, a mushroom-based coffee alternative
[https://www.mudwtr.com/mindmatter]
Discount Code ($5 off) = MINDMATTER
Organize your digital highlights & notes w/ Readwise (2 months free w/ subscription)
[https://readwise.io/nickjikomes/]
Start your own podcast (get $20 Amazon gift card after signup)
[https://www.buzzsprout.com/?referrer_id=1507198]
Buy Mind & Matter T-Shirts
[https://www.etsy.com/shop/OURMIND?ref=simple-shop-header-name&listing_id=1036758072§ion_id=34648633]
Connect with Nick Jikomes on Twitter
[https://twitter.com/trikomes]
Learn more about our podcast sponsor, Dosist
[https://dosist.com/]
ABOUT Nick Jikomes:
Nick is a neuroscientist and podcast host. He is currently Director of Science & Innovation at Leafly, a technology startup in the legal cannabis industry. He received a Ph.D. in Neuroscience from Harvard University and a B.S. in Genetics from the University of Wisconsin-Madison.
Support the show (https://www.patreon.com/nickjikomes)
